| Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders (NCT07748221) | Istituto Oncologico Veneto IRCCS | 2026-09-01 |
| IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors (NCT07185568) | Istituto Oncologico Veneto IRCCS | 2026-08-04 |
| Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study (NCT07613151) | Istituto Oncologico Veneto IRCCS | 2026-05-01 |
| VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures (NCT07338292) | Istituto Oncologico Veneto IRCCS | 2025-12-17 |
| Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients (NCT06964815) | Istituto Oncologico Veneto IRCCS | 2025-11-12 |
| Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery (NCT06941194) | Istituto Oncologico Veneto IRCCS | 2025-09-15 |
| Using Virtual Reality During PICC and PICC-PORT Placement in Cancer Patients (NCT07384741) | Istituto Oncologico Veneto IRCCS | 2025-09-05 |
| Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype (NCT06753136) | Istituto Oncologico Veneto IRCCS | 2025-07-23 |
| Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies. (NCT06955910) | Istituto Oncologico Veneto IRCCS | 2025-06-18 |
| Novel Therapeutic Approach for Human T-cell Malignancies (NCT06600568) | Istituto Oncologico Veneto IRCCS | 2025-03-18 |
| A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer (NCT06245603) | Istituto Oncologico Veneto IRCCS | 2024-12-20 |
| Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) (NCT06155279) | Istituto Oncologico Veneto IRCCS | 2024-11-06 |
| Regorafenib for Recurrent Meningioma (MIRAGE Trial) (NCT06275919) | Istituto Oncologico Veneto IRCCS | 2024-09-23 |
| Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung Cancer (NCT06595498) | Istituto Oncologico Veneto IRCCS | 2024-07-01 |
| Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study (NCT06906237) | Istituto Oncologico Veneto IRCCS | 2024-04-18 |
| ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study (NCT06134440) | Istituto Oncologico Veneto IRCCS | 2023-11-21 |
| Immune Microenvironment and Gene Expression Profiling in Mesothelioma (NCT06581549) | Istituto Oncologico Veneto IRCCS | 2023-11-02 |
| Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management (NCT06133465) | Istituto Oncologico Veneto IRCCS | 2023-10-15 |
| OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate (NCT06273345) | Istituto Oncologico Veneto IRCCS | 2023-01-23 |
| Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (NCT06095375) | Istituto Oncologico Veneto IRCCS | 2022-07-04 |
| An Integrated Radio-immunological Approach (NCT05267509) | Istituto Oncologico Veneto IRCCS | 2022-02-23 |
| Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS (NCT04810182) | Istituto Oncologico Veneto IRCCS | 2020-09-10 |
| Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study (NCT04811781) | Istituto Oncologico Veneto IRCCS | 2020-06-04 |
| Risk-Based Breast Screening in Young Women (NCT05675085) | Istituto Oncologico Veneto IRCCS | 2020-01-20 |
| Conservative Management of CIN2 Lesions and Biomarkers Evaluation (NCT04687267) | Istituto Oncologico Veneto IRCCS | 2019-04-15 |
| Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma (NCT04416646) | Istituto Oncologico Veneto IRCCS | 2019-02-27 |
| Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients (NCT04656262) | Istituto Oncologico Veneto IRCCS | 2018-09-10 |
| First Line Osimertinib in the Real World: an Inter-regional Prospective Study (NCT04965701) | Istituto Oncologico Veneto IRCCS | 2018-06-01 |
| First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer (NCT03451370) | Istituto Oncologico Veneto IRCCS | 2017-11-01 |
| The GOLD Study: G8 in OLDer Patients (NCT03449914) | Istituto Oncologico Veneto IRCCS | 2017-10-26 |
| Immunophenotyping of Metastases From Colorectal Cancer (NCT03604926) | Istituto Oncologico Veneto IRCCS | 2017-10-05 |
| Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients (NCT04659551) | Istituto Oncologico Veneto IRCCS | 2017-10-05 |